Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…
New Delhi, November 20, 2018: This yearat theEastern Economic Forum in Vladivostok, BIOCAD andShanghai Pharmaceuticals Holdingentered into a Memorandum of…
New Delhi, April 28, 2018: In March 2018, BIOCAD analyzed results from its Phase II study in which the original…
New Delhi, February 21, 2018: In January 2018, BIOCAD’s infliximab biosimilar was approved in Russia. The approval was based on…